These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 15058315)

  • 1. Treating obesity: pharmacology of energy expenditure.
    Clapham JC
    Curr Drug Targets; 2004 Apr; 5(3):309-23. PubMed ID: 15058315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What do pharmacological approaches to obesity management offer? Linking pharmacological mechanisms of obesity management agents to clinical practice.
    Astrup A; Lundsgaard C
    Exp Clin Endocrinol Diabetes; 1998; 106 Suppl 2():29-34. PubMed ID: 9792479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacotherapy for obesity.
    Ioannides-Demos LL; Proietto J; McNeil JJ
    Drugs; 2005; 65(10):1391-418. PubMed ID: 15977970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phytochemicals in regulating fatty acid β-oxidation: Potential underlying mechanisms and their involvement in obesity and weight loss.
    Rupasinghe HP; Sekhon-Loodu S; Mantso T; Panayiotidis MI
    Pharmacol Ther; 2016 Sep; 165():153-63. PubMed ID: 27288729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug treatment of obesity: established and emerging therapies.
    Isidro ML; Cordido F
    Mini Rev Med Chem; 2009 Jun; 9(6):664-73. PubMed ID: 19519492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pharmacotherapy for obesity: current drugs and those in advanced development.
    Halford JC
    Curr Drug Targets; 2004 Oct; 5(7):637-46. PubMed ID: 15473253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies and potential molecular targets for obesity treatment.
    Campfield LA; Smith FJ; Burn P
    Science; 1998 May; 280(5368):1383-7. PubMed ID: 9603722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medicinal strategies in the treatment of obesity.
    Bray GA; Tartaglia LA
    Nature; 2000 Apr; 404(6778):672-7. PubMed ID: 10766254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of topiramate on energy balance in obese men: a 6-month double-blind randomized placebo-controlled study with a 6-month open-label extension.
    Tremblay A; Chaput JP; Bérubé-Parent S; Prud'homme D; Leblanc C; Alméras N; Després JP
    Eur J Clin Pharmacol; 2007 Feb; 63(2):123-34. PubMed ID: 17200837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rimonabant for the treatment of overweight and obese people.
    Burch J; McKenna C; Palmer S; Norman G; Glanville J; Sculpher M; Woolacott N
    Health Technol Assess; 2009 Oct; 13 Suppl 3():13-22. PubMed ID: 19846024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The discovery and status of sibutramine as an anti-obesity drug.
    Luque CA; Rey JA
    Eur J Pharmacol; 2002 Apr; 440(2-3):119-28. PubMed ID: 12007530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity pharmacotherapy: current perspectives and future directions.
    Misra M
    Curr Cardiol Rev; 2013 Feb; 9(1):33-54. PubMed ID: 23092275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological treatment of obesity: present status.
    Scheen AJ; Lefébvre PJ
    Int J Obes Relat Metab Disord; 1999 Feb; 23 Suppl 1():47-53. PubMed ID: 10193862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term pharmacotherapy for obesity and overweight.
    Padwal R; Li SK; Lau DC
    Cochrane Database Syst Rev; 2003; (4):CD004094. PubMed ID: 14584004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translational Pharmacology and Physiology of Brown Adipose Tissue in Human Disease and Treatment.
    Larson CJ
    Handb Exp Pharmacol; 2019; 251():381-424. PubMed ID: 30689089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-obesity drugs: what does sibutramine offer? An analysis of its potential contribution to obesity treatment.
    Van Gaal LF; Wauters MA; De Leeuw IH
    Exp Clin Endocrinol Diabetes; 1998; 106 Suppl 2():35-40. PubMed ID: 9792480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amylin improves the effect of leptin on insulin sensitivity in leptin-resistant diet-induced obese mice.
    Kusakabe T; Ebihara K; Sakai T; Miyamoto L; Aotani D; Yamamoto Y; Yamamoto-Kataoka S; Aizawa-Abe M; Fujikura J; Hosoda K; Nakao K
    Am J Physiol Endocrinol Metab; 2012 Apr; 302(8):E924-31. PubMed ID: 22275759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacotherapy for obesity.
    Halford JC
    Appetite; 2006 Jan; 46(1):6-10. PubMed ID: 16229924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased energy expenditure contributes more to the body weight-reducing effect of rimonabant than reduced food intake in candy-fed wistar rats.
    Herling AW; Kilp S; Elvert R; Haschke G; Kramer W
    Endocrinology; 2008 May; 149(5):2557-66. PubMed ID: 18276749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.